Figure 3. Overall survival (OS) for patients with NK/T-cell lymphoma with different pretreatment serum albumin to globulin ratios (AGRs) according to treatment modalities.
OS for patients with a pretreatment AGR ≥ 1.3 (solid line) or <1.3 (dashed line) who received (A) chemotherapy alone, (B) radiotherapy with or without chemotherapy, (C) anthracycline-based chemotherapy, or (D) asparaginase-containing chemotherapy.